Cargando…

1256. In Vivo Activity and Structural Characterization of a New Generation γ-Lactam Siderophore Antibiotic Against Multidrug-Resistant Gram-Negative Bacteria and Acinetobacter spp

BACKGROUND: Multidrug-resistant (MDR) A. baumannii presents a critical need for innovative antibacterial development. We have identified a new series of γ-lactam (oxopyrazole) antibiotics that target penicillin binding proteins (PBPs) and incorporate a siderophore moiety to facilitate periplasmic up...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goldberg, Joel, Bethel, Christopher, Hujer, Andrea M, Marshall, Steven, Taracila, Magdalena A, Papp-Wallce, Krisztina M, Kumar, Vijay, van den Akker, Focco, Plummer, Mark, Bonomo, Robert A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776719/ http://dx.doi.org/10.1093/ofid/ofaa439.1440

Ejemplares similares

687. In vitro Activity of a New Generation Oxopyrazole Antibiotic Against Acinetobacter spp.
por: Goldberg, Joel, et al.
Publicado: (2019)

698. In vitro Activity of a New Generation Oxopyrazole Antibiotic Against Multidrug-Resistant Gram-Negative Bacilli
por: Goldberg, Joel, et al.
Publicado: (2019)

Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent
por: Barnes, Melissa D., et al.
Publicado: (2019)

The Novel β-Lactamase Inhibitor, ETX-2514, in Combination with Sulbactam Effectively Inhibits Acinetobacter baumannii
por: Barnes, Melissa D, et al.
Publicado: (2017)

1437. Biochemical characterization of L1 and L2 β-lactamases from clinical isolates of Stenotrophomonas maltophilia
por: Mojica, Maria F, et al.
Publicado: (2020)

1063. ARGONAUT-V: Susceptibility of Multidrug-Resistant (MDR) Pseudomonas aeruginosa to Cefepime-Taniborbactam
por: Mack, Andrew R, et al.
Publicado: (2021)

Structural Characterization of Diazabicyclooctane β-Lactam “Enhancers” in Complex with Penicillin-Binding Proteins PBP2 and PBP3 of Pseudomonas aeruginosa
por: Rajavel, Malligarjunan, et al.
Publicado: (2021)

Detection of SHV β-lactamases in Gram-negative bacilli using fluorescein-labeled antibodies
por: Hujer, Andrea M, et al.
Publicado: (2009)

Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study
por: Krishnan, Nikhil P., et al.
Publicado: (2015)

Multidrug-resistant Acinetobacter pittii is adapting to and exhibiting potential succession aboard the International Space Station
por: Tierney, Braden T., et al.
Publicado: (2022)

1286. Taniborbactam Inhibits Cefepime-Hydrolyzing Variants of Pseudomonas-derived Cephalosporinase (PDC)
por: Mack, Andrew R, et al.
Publicado: (2021)

Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa
por: Barnes, Melissa D., et al.
Publicado: (2018)

In Vitro Activity of Cefiderocol, a Siderophore Cephalosporin, against Multidrug-Resistant Gram-Negative Bacteria
por: Mushtaq, Shazad, et al.
Publicado: (2020)

2558. Predicting β-Lactam Resistance Using Whole Genome Sequencing (WGS) in Klebsiella pneumoniae: The Challenge of β-Lactam Inhibitors
por: Hujer, Andrea, et al.
Publicado: (2018)

Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses
por: Alsenani, Tahani A., et al.
Publicado: (2023)

1642. A Novel β-lactamase Inhibitor (Durlobactam, DUR) and β-Lactams Enhance Susceptibility Against Multidrug-Resistant (MDR) Mycobacterium abscessus (Mab)
por: Dousa, Khalid M, et al.
Publicado: (2020)

The Effectiveness of Imipenem–Relebactam against Ceftazidime-Avibactam Resistant Variants of the KPC-2 β-Lactamase
por: Papp-Wallace, Krisztina M., et al.
Publicado: (2023)

2806. The Mechanism of β-Lactam Antibiotic Action: Structural Analysis of Mycobacterium abscessus l,d-Transpeptidases, d,d-Carboxypeptidase and penicillin-binding-proteins binding by imipenem, ceftaroline, and amoxicillin
por: Shin, Eunjeong, et al.
Publicado: (2023)

Exploring Additional Dimensions of Complexity in Inhibitor Design for Serine β-Lactamases: Mechanistic and Intra- and Inter-molecular Chemistry Approaches
por: van den Akker, Focco, et al.
Publicado: (2018)

Multidrug-Resistant Acinetobacter spp.: Increasingly Problematic Nosocomial Pathogens
por: Lee, Kyungwon, et al.
Publicado: (2011)

AAI101, a Novel β-Lactamase Inhibitor: Microbiological and Enzymatic Profiling
por: Papp-Wallace, Krisztina M, et al.
Publicado: (2017)

Activity of siderophores against drug-resistant Gram-positive and Gram-negative bacteria
por: Gokarn, Karuna, et al.
Publicado: (2018)

Siderophores as “Trojan Horses”: tackling multidrug resistance?
por: de Carvalho, Carla C. C. R., et al.
Publicado: (2014)

Molecular Investigations of PenA-mediated β-lactam Resistance in Burkholderia pseudomallei
por: Rholl, Drew A., et al.
Publicado: (2011)

A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii
por: Hujer, Andrea M., et al.
Publicado: (2021)

Structures of SHV-1 β-Lactamase with Penem and Penam Sulfone Inhibitors That Form Cyclic Intermediates Stabilized by Carbonyl Conjugation
por: Ke, Wei, et al.
Publicado: (2012)

1351. In vitro Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, Against Enterobacteriaceae With Defined Extended-Spectrum Β-Lactamases and Carbapenemases
por: Jacobs, Michael R, et al.
Publicado: (2018)

Structural Analysis of The OXA-48 Carbapenemase Bound to A “Poor” Carbapenem Substrate, Doripenem
por: Papp-Wallace, Krisztina M., et al.
Publicado: (2019)

Human Pleural Fluid and Human Serum Albumin Modulate the Behavior of a Hypervirulent and Multidrug-Resistant (MDR) Acinetobacter baumannii Representative Strain
por: Pimentel, Camila, et al.
Publicado: (2021)

Molecular Epidemiology of Aminoglycosides Resistance in Acinetobacter Spp. with Emergence of Multidrug-Resistant Strains
por: Moniri, R, et al.
Publicado: (2010)

Novel Beta Lactam Antibiotics for the Treatment of Multidrug-Resistant Gram-Negative Infections in Children: A Narrative Review
por: Venuti, Francesco, et al.
Publicado: (2023)

Role of Catecholate Siderophores in Gram-Negative Bacterial Colonization of the Mouse Gut
por: Pi, Hualiang, et al.
Publicado: (2012)

133. ARGONAUT-III: Susceptibility of Carbapenem-resistant Klebsiellae to Cefepime-Taniborbactam
por: Mack, Andrew R, et al.
Publicado: (2021)

1055. ARGONAUT-IV: Susceptibility of Carbapenem-resistant Klebsiellae to Ceftibuten/VNRX-5236
por: Mack, Andrew R, et al.
Publicado: (2021)

1445. Deciphering the Role of the Y221H Ω-loop Substitution in Pseudomonas-derived Cephalosporinase (PDC) in Cephalosporin Resistance
por: Mack, Andrew R, et al.
Publicado: (2020)

Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance
por: Watkins, Richard R., et al.
Publicado: (2013)

Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment
por: Wright, Meredith S., et al.
Publicado: (2016)

In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against Carbapenem-Nonsusceptible and Multidrug-Resistant Isolates of Gram-Negative Bacilli Collected Worldwide in 2014 to 2016
por: Hackel, Meredith A., et al.
Publicado: (2018)

In vitro synergistic activity of colistin and teicoplanin combination against multidrug-resistant Acinetobacter spp
por: Rady, Osama Mohamed Samy Mohamed, et al.
Publicado: (2022)

Multidrug-resistant Acinetobacter spp. from hospital intensive care units in Brazilian Amazon
por: da Silva, Marcos Eduardo Passos, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tmdnh87rtbuuhmm5togfjjrjso